Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Complete Biotransformation of Protopanaxatriol-Type Ginsenosides in Panax ginseng Leaf Extract to Aglycon Protopanaxatriol by β-Glycosidases from Dictyoglomus turgidum and Pyrococcus furiosus

  • Yang, Eun-Joo (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Shin, Kyung-Chul (Department of Bioscience and Biotechnology, Konkuk University) ;
  • Lee, Dae Young (Department of Herbal Crop Research, National Institute of Horticultural and Herbal Science, RDA) ;
  • Oh, Deok-Kun (Department of Bioscience and Biotechnology, Konkuk University)
  • Received : 2017.09.25
  • Accepted : 2017.11.24
  • Published : 2018.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Aglycon protopanaxatriol (APPT) has valuable pharmacological effects such as memory enhancement and tumor inhibition. ${\beta}$-Glycosidase from the hyperthermophilic bacterium Dictyoglomus turgidum (DT-bgl) hydrolyzes the glucose residues linked to APPT, but not other glycoside residues. ${\beta}$-Glycosidase from the hyperthermophilic bacterium Pyrococcus furiosus (PF-bgl) hydrolyzes the outer sugar at C-6 but not the inner glucose at C-6 or the glucose at C-20. Thus, the combined use of DT-bgl and PF-bgl is expected to increase the biotransformation of PPT-type ginsenosides to APPT. We optimized the ratio of PF-bgl to DT-bgl, the concentrations of substrate and enzyme, and the reaction time to increase the biotransformation of ginsenoside Re and PPT-type ginsenosides in Panax ginseng leaf extract to APPT. DT-bgl combined with PF-bgl converted 1.0 mg/ml PPT-type ginsenosides in ginseng leaf extract to 0.58 mg/ml APPT without other ginsenosides, with a molar conversion of 100%. We achieved the complete biotransformation of ginsenoside Re and PPT-type ginsenosides in ginseng leaf extract to APPT by the combined use of two ${\beta}$-glycosidases, suggesting that discarded ginseng leaves can be used as a source of the valuable ginsenoside APPT. To the best of our knowledge, this is the first quantitative production of APPT using ginsenoside Re, and we report the highest concentration and productivity of APPT from ginseng extract to date.

Keywords

References

  1. Shin KC, Oh DK. 2016. Classification of glycosidases that hydrolyze the specific positions and types of sugar moieties in ginsenosides. Crit. Rev. Biotechnol. 36: 1036-1049. https://doi.org/10.3109/07388551.2015.1083942
  2. Xie JT, Mehendale SR, Li X, Quigg R, Wang X, Wang CZ, et al. 2005. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim. Biophys. Acta 1740: 319-325. https://doi.org/10.1016/j.bbadis.2004.10.010
  3. Cheng Y, Shen LH, Zhang JT. 2005. Anti-amnestic and antiaging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol. Sin. 26: 143-149. https://doi.org/10.1111/j.1745-7254.2005.00034.x
  4. Kim HJ, Kim P, Shin CY. 2013. A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system. J. Ginseng Res. 37: 8-29. https://doi.org/10.5142/jgr.2013.37.8
  5. Li N, Liu Y, Li W, Zhou L, Li Q, Wang X, et al. 2016. A UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's disease. J. Ginseng Res. 40: 9-17. https://doi.org/10.1016/j.jgr.2015.04.006
  6. Lee EH, Cho SY, Kim SJ, Shin ES, Chang HK, Kim DH, et al. 2003. Ginsenoside F1 protects human HaCaT keratinocytes from ultraviolet-B-induced apoptosis by maintaining constant levels of Bcl-2. J. Invest. Dermatol. 121: 607-613. https://doi.org/10.1046/j.1523-1747.2003.12425.x
  7. Jeong JJ, Van Le TH, Lee SY, Eun SH, Nguyen MD, Park JH, et al. 2015. Anti-inflammatory effects of vina-ginsenoside R2 and majonoside R2 isolated from Panax vietnamensis and their metabolites in lipopolysaccharide-stimulated macrophages. Int. Immunopharmacol. 28: 700-706. https://doi.org/10.1016/j.intimp.2015.07.025
  8. Kim MK, Lee JW, Lee KY, Yang DC. 2005. Microbial conversion of major ginsenoside Rb1 to pharmaceutically active minor ginsenoside Rd. J. Microbiol. 43: 456-462.
  9. Bae EA, Shin JE, Kim DH. 2005. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect. Biol. Pharm. Bull. 28: 1903-1908. https://doi.org/10.1248/bpb.28.1903
  10. Wang YZ, Chen J, Chu SF, Wang YS, Wang XY, Chen NH, et al. 2009. Improvement of memory in mice and increase of hippocampal excitability in rats by ginsenoside Rg1's metabolites ginsenoside Rh1 and protopanaxatriol. J. Pharmacol. Sci. 109: 504-510. https://doi.org/10.1254/jphs.08060FP
  11. Hasegawa H, Suzuki R, Nagaoka T, Tezuka Y, Kadota S, Saiki I. 2002. Prevention of growth and metastasis of murine melanoma through enhanced natural-killer cytotoxicity by fatty acid-conjugate of protopanaxatriol. Biol. Pharm. Bull. 25: 861-866.
  12. Cui CH, Kim SC, Im WT. 2013. Characterization of the ginsenoside-transforming recombinant beta-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides. Appl. Microbiol. Biotechnol. 97: 649-659. https://doi.org/10.1007/s00253-012-4324-5
  13. Liu L, Gu LJ, Zhang DL, Wang Z, Wang CY, Li Z, et al. 2010. Microbial conversion of rare ginsenoside Rf to 20(S)-protopanaxatriol by Aspergillus niger. Biosci. Biotechnol. Biochem. 74: 96-100. https://doi.org/10.1271/bbb.90596
  14. Lee GW, Yoo MH, Shin KC, Kim KR, Kim YS, Lee KW, et al. 2013. Beta-glucosidase from Penicillium aculeatum hydrolyzes exo-, 3-O-, and 6-O-beta-glucosides but not 20-O-beta-glucoside and other glycosides of ginsenosides. Appl. Microbiol. Biotechnol. 97: 6315-6324.
  15. Wang DM, Yu HS, Song JG, Xu YF, Jin FX. 2012. Enzyme kinetics of ginsenosidase type IV hydrolyzing 6-O-multiglycosides of protopanaxatriol type ginsenosides. Process Biochem. 47: 133-138. https://doi.org/10.1016/j.procbio.2011.10.026
  16. Lee HJ, Shin KC, Lee GW, Oh DK. 2014. Production of aglycone protopanaxatriol from ginseng root extract using Dictyoglomus turgidum beta-glycosidase that specifically hydrolyzes the xylose at the C-6 position and the glucose in protopanaxatriol-type ginsenosides. Appl. Microbiol. Biotechnol. 98: 3659-3667. https://doi.org/10.1007/s00253-013-5302-2
  17. Hu JN, Lee JH, Shin JA, Choi JE, Lee KT. 2008. Determination of ginsenosides content in Korean ginseng seeds and roots by high performance liquid chromatography. Food Sci Biotechnol. 17: 430-433.
  18. Shi W, Wang YT, Li J, Zhang HQ, Ding L. 2007. Investigation of ginsenosides in different parts and ages of Panax ginseng. Food Chem. 102: 664-668. https://doi.org/10.1016/j.foodchem.2006.05.053
  19. Yahara S, Matsuura K, Kasai R, Tanaka O. 1976. Saponins of buds and flowers of Panax ginseng CA Meyer. (1). Isolation of ginsenosides Rd, Re, and Rg1. Chem. Pharm. Bull. 24: 3212-3213. https://doi.org/10.1248/cpb.24.3212
  20. Shin KC, Lee HJ, Oh DK. 2015. Substrate specificity of betaglucosidase from Gordonia terrae for ginsenosides and its application in the production of ginsenosides Rg3, Rg2, and Rh1 from ginseng root extract. J. Biosci. Bioeng. 119: 497-504.
  21. Oh HJ, Shin KC, Oh DK. 2014. Production of ginsenosides Rg1 and Rh1 by hydrolyzing the outer glycoside at the C-6 position in protopanaxatriol-type ginsenosides using ${\beta}$-glucosidase from Pyrococcus furiosus. Biotechnol. Lett. 36: 113-119. https://doi.org/10.1007/s10529-013-1331-2

Cited by

  1. Biotransformation of Glycoginsenosides to Intermediate Products and Aglycones using a Hemicellulosome Produced by Cellulosimicrobium cellulan vol.55, pp.2, 2019, https://doi.org/10.1134/s0003683819020054